Stem cell marker expression in small cell lung carcinoma and developing lung tissue

LK Koch, H Zhou, J Ellinger, K Biermann, T Höller… - Human pathology, 2008 - Elsevier
… epithelial cells in half of the cases of normal tumor adjacent … cell lung cancers and clustered
epithelial cells in developing proximal bronchi share the expression of stem cell markers

[HTML][HTML] Systematic correlation analyses of circulating tumor cells with clinical variables and tumor markers in lung cancer patients

X Wang, K Ma, Z Yang, J Cui, H He, AR Hoffman… - … of Cancer, 2017 - ncbi.nlm.nih.gov
… with clinical variables and tumor markers in a cohort of lung cancer patients. Using the … in
both small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) patients prior to …

Genetic markers in lung cancer diagnosis: a review

K Wadowska, I Bil-Lula, Ł Trembecki… - International journal of …, 2020 - mdpi.com
… diagnosis of non-small cell lung carcinoma (NSCLC), while tumor markers, such as CEA (…
cell carcinoma antigen) do not make the diagnosis possible at the early stage of lung cancer [4]…

Clinical evaluation of tumor markers for diagnosis in patients with non-small cell lung cancer in China

L Ma, XW Xie, HY Wang, LY Ma… - … Pacific journal of cancer …, 2015 - koreascience.kr
… Now, it is confirmed that CA125 is an important marker in diagnosis of lung cancer. In this
study, serum CA199 in patients with NSCLC were significantly higher than those with lung

Value of serum tumor markers for predicting EGFR mutations in non-small cell lung cancer patients

L Wen, S Wang, W Xu, X Xu, M Li, Y Zhang… - Annals of Diagnostic …, 2020 - Elsevier
… are related to EGFR gene mutation in non-small cell lung cancer is remains controversial
[14,… of serum tumor markers with respect to EGFR gene mutation in non-small cell lung cancer

[HTML][HTML] A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers

TA D'Amico, M Massey, JE Herndon II… - The Journal of thoracic …, 1999 - Elsevier
… This study evaluates a panel of molecular markers in a large population of patients with
stage I non–small cell lung cancer to determine the prognostic value of each marker and to …

Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways

G Leon, L MacDonagh, SP Finn, S Cuffe… - Pharmacology & …, 2016 - Elsevier
… for monitoring the progress of cancer therapy and for evaluating … of cancer stem cell markers
in treatment-resistant lung cancer cells and the signaling cascades activated by these cells

Serum tumor markers in non‐small cell lung cancer. A comparative analysis

ML Margolis, JB Hyzy, LL Schenken, BS Schepart - Cancer, 1994 - Wiley Online Library
… (MoAb) to detect tumor-associated antigens (TAA) in the sera of patients with lung cancer.'-'' …
MoAb reactive against lung tumor tissue from biopsy and cultured cell lines and selected …

[HTML][HTML] PGP9. 5 as a candidate tumor marker for non-small-cell lung cancer

K Hibi, WH Westra, M Borges, S Goodman… - The American journal of …, 1999 - Elsevier
lung cancer, we first studied PGP9.5 expression in normal lung and a panel of lung cancer
cell … 98 resected primary non-small-cell lung cancers (NSCLCs), using immunohistochemistry …

ADAM8 as a novel serological and histochemical marker for lung cancer

N Ishikawa, Y Daigo, W Yasui, K Inai, H Nishimura… - Clinical cancer …, 2004 - AACR
lung cancer cell lines used in this study included nine adenocarcinomas (A427, A549,
LC319, NCI-H1373, PC-3, PC-9, PC-14, NCI-H1666, and NCI-H1781), nine squamous cell